ARCHIVES

ODAC Recommends TICE BCG Approval For Recurrent Bladder Cancer Prevention

This article is from The Cancer Letter archive.

Vol. 23 No. 01 | January 10, 1997

Download PDF Visit The Full Archive

Related Articles

DCCP Board Okays Concepts For Severn Contract Recompetitions, Denies Two Other

June 19, 1981

Science Policy: Stem Cell Research Guidelines Formalize NIH Funding Polices

December 3, 1999

An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists.

May 13, 2005

Low-Income Women Lack Mammography Access: Survey

May 14, 1993

Breast Cancer Progress Report Summaries

November 14, 1975

NTP Plans Look At Radiation, Viruses, In Carcinogen Report.

July 27, 2001